Premium
Supplementation with Docosahexaenoic Acid and Vitamin E Improves Hepatic Triglyceride Accumulation Induced by High‐Fat Diet in Mice
Author(s) -
Yuan Gaofeng,
Xu Mengmeng,
Tan Meijuan,
Dong Jian,
Chen Xiaoe
Publication year - 2021
Publication title -
european journal of lipid science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.614
H-Index - 94
eISSN - 1438-9312
pISSN - 1438-7697
DOI - 10.1002/ejlt.202000224
Subject(s) - steatosis , docosahexaenoic acid , medicine , oxidative stress , endocrinology , triglyceride , vitamin e , fatty liver , antioxidant , glutathione , chemistry , vitamin c , cholesterol , fatty acid , biology , biochemistry , polyunsaturated fatty acid , enzyme , disease
The study aims to investigate the effect of combined supplementation with docosahexaenoic acid (C22:6 n‐3, DHA) and vitamin E (VE) on the oxidative stress and liver triglycerides (TG) accumulation induced by high‐fat diet (HFD) in mice. C57BL/6J mice are fed either a control diet or an HFD for 8 weeks. Animals are supplemented with DHA, VE, or DHA + VE, respectively. Supplementation with DHA alone shows significant improvement in oxidative stress and hepatic steatosis in mice. Supplementation with DHA significantly reduces the liver TG and total cholesterol contents, and the alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, compared with the HFD. Supplementation with DHA also significantly decreases the mRNA expression level of sterol regulatory element‐binding protein 1C. However, supplementation with VE alone does not show improvement in oxidative stress and hepatic steatosis. DHA + VE supply obtains a superior effect in alleviation of hepatic steatosis than DHA supplementation alone in mice fed by HFD. The efficacy of DHA potentiated by VE can be due to that VE enhances the effect of DHA in decrease of ALT and AST levels and increase of antioxidant enzyme activity and glutathione level in mice fed by HFD. Practical Applications : Supplementation with DHA significantly improves the oxidative stress and hepatic steatosis induced by HFD in mice. The efficacy of DHA in the alleviation of hepatic steatosis induced by HFD is potentiated by VE. These findings may provide a rational basis for the use of DHA and VE co‐supplementation in patients with liver steatosis.